Samuel Ejadi
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 10
- Cutaneous Melanoma Detection and Management 2
-
- Prostate Cancer Treatment and Research 4
- Co-authors
- Sanatan Saraf (5 shared papers)Roger B. Cohen (4 shared papers)Aaron Richard Hansen (4 shared papers)Sarina Anne Piha-Paul (6 shared papers)Emilie M.J. van Brummelen (5 shared papers)John M. Wallmark (4 shared papers)Patrick Alexander Ott (4 shared papers)Pradeep Thanigaimani (3 shared papers)
- Journals
- Annals of Oncology (7 papers)European Journal of Cancer (5 papers)Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)Medical Oncology (1 paper)
- Partner nations
- United StatesSouth KoreaFrance
In The Last Decade
Samuel Ejadi
25 papers receiving 2.5k citations
Samuel Ejadi's Hit Papers
Peers
Comparison fields: 5 of 71
- Otorhinolaryngology 262
- Cancer Research 545
- Oncology 861
- Pulmonary and Respiratory Medicine 336
- Immunology 146
Countries citing papers authored by Samuel Ejadi
This map shows the geographic impact of Samuel Ejadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Ejadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Ejadi more than expected).
Fields of papers citing papers by Samuel Ejadi
This network shows the impact of papers produced by Samuel Ejadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Ejadi. The network helps show where Samuel Ejadi may publish in the future.
Co-authors
The 25 scholars most cited alongside Samuel Ejadi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours Hit paper breakdown → | 2020 | 770 |
| 2 | Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study Hit paper breakdown → | 2017 | 375 |
| 3 | Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study Hit paper breakdown → | 2018 | 306 |
| 4 | 2017 | 241 | |
| 5 | 2016 | 209 | |
| 6 | 2017 | 202 | |
| 7 | 2008 | 104 | |
| 8 | 1988 | 96 | |
| 9 | 2008 | 84 | |
| 10 | 2016 | 40 | |
| 11 | 2019 | 25 | |
| 12 | 2020 | 24 | |
| 13 | 2015 | 16 | |
| 14 | 2015 | 15 | |
| 15 | 2018 | 15 | |
| 16 | 2014 | 13 | |
| 17 | 2015 | 13 | |
| 18 | 2015 | 9 | |
| 19 | 2015 | 9 | |
| 20 | 2015 | 7 |
About Samuel Ejadi
Samuel Ejadi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Cancer Research and Immunology, having authored 26 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Prostate Cancer Treatment and Research (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Colorectal and Anal Carcinomas (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Head and Neck Cancer Studies (2 papers), Immunotherapy and Immune Responses (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). The work is most often cited by research in Otorhinolaryngology (262 citations), Cancer Research (545 citations), Oncology (861 citations), Pulmonary and Respiratory Medicine (336 citations) and Immunology (146 citations). Samuel Ejadi has collaborated with scholars based in United States, South Korea and France. Frequent co-authors include Sanatan Saraf, Roger B. Cohen, Aaron Richard Hansen, Sarina Anne Piha-Paul, Emilie M.J. van Brummelen, John M. Wallmark, Patrick Alexander Ott, Pradeep Thanigaimani, Christophe Le Tourneau and Caroline Even. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.